Navigation Links
Denali Concrete Management Inc. Announces the Commencement of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study
Date:12/21/2011

tment of autoimmune inflammatory diseases including Rheumatoid Arthritis (Phase 2b) and Psoriasis (Phase 2/3).

About OphthaliX Inc (formerly Denali Concrete Management Inc).

OphthaliX Inc. (OTCBB: DCMG) is an advanced clinical-stage biopharmaceutical company focused on developing therapeutic products for the treatment of ophthalmic disorders. Denali's product candidate, CF101, is being developed to treat three ophthalmic indications: dry eye syndrome; glaucoma and uveitis.

This release contains forward-looking statements regarding Denali Concrete Management, Inc.'s future plans and expected performance based on assumptions the Company believes to be reasonable.  A number of risks and uncertainties could cause actual results to differ materially from these statements, including, without limitation, the success rate of business development efforts and the timeliness of development activities, and other risk factors described from time to time in the Company's reports filed with the SEC.  In addition, the Company operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond the Company's control. Denali Concrete Management, Inc. undertakes no obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise. 


'/>"/>
SOURCE Denali Concrete Management Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Denali Concrete Management Inc. Announces its Acquisition of CF101 for Ophthalmic Indications and the Completion of Above $6 Million Private Placement at $1.144 Per Share
2. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
3. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
4. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
5. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
6. U.S. Preventive Medicine Acquires Specialty Disease Management
7. Cellectar Expands Clinical Management Team
8. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
9. New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
10. Lilly Receives NCQA Design Certification for Depression Care Management Program
11. Micromet Announces Changes in Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... ORLANDO, Fla. , Nov. 21, 2014 MEDITE ... 2014 reported nine months and the 3 rd quarter ... million. Operating income was $448,000 for the nine months ended ... September 2014. "Even though our 3 rd quarter is ... period which extends from July into September for many countries ...
(Date:11/21/2014)... , Nov. 21, 2014  The University of Maryland,s ... the ceremonial groundbreaking of the new A. James Clark ... new building will cultivate transformative new engineering and biomedical ... Taking place at 10:00 a.m. on November 21 at ... Branch Parking Lot, adjacent to the Jeong H. Kim ...
(Date:11/21/2014)... Nov. 21, 2014  World Hemp Oil, an importer ... announces they are now offering legal, organic oil with ... type strains grown in medical marijuana states. People suffering ... such as Parkinson,s, MS, and spinal cord injury, no ... pass, because imported CBD Oil Is legal in all ...
Breaking Medicine Technology:CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3
... ALBANY, New York, May 3, 2012 ... Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 ... 206 tables and figures. Worldwide markets are poised to achieve ... improve clinical care delivery to patients with chronic disease, decreasing ...
... (NASDAQ: OMER ) today announced that it ... four additional orphan G protein-coupled receptors (GPCRs). Without compounds ... those receptors is extremely difficult. Omeros has now unlocked ... Class A orphan GPCRs. There are approximately 120 orphan ...
Cached Medicine Technology:ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 2ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 3ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 4ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 5ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 6ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 7ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report 8Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio 2Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio 3Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio 4
(Date:11/23/2014)... iFitDress.com, a well-known wedding dress manufacturer, has unveiled its new ... are now offered at deeply discounted prices, up to 75 ... Dec. 15. The main purpose of the promotion is to ... items are ideal options for ladies who are eager to ... its new mint cocktail dresses are very beautiful; they are ...
(Date:11/23/2014)... 2014 Nearly 260 testosterone lawsuits ... deep vein thrombosis and other serious cardiovascular events ... litigation (MDL) underway in the Northern District of ... documents updated on November 17th by the U.S. ... filing of 259 lawsuits against the makers of ...
(Date:11/23/2014)... To show thanks to new and old customers, iFitDress.com ... dresses for weddings. Customers who need custom outfits can ... distinguished dress manufacturer, and it is among the ones which ... very long time. The CEO of this company says, "iFitDress.com ... to buy not only a beautiful dress, but also a ...
(Date:11/23/2014)... 2014 “BlackVue” was featured on NewsWatch ... which features the latest and coolest technology products available ... for NewsWatch, conducted the product review and shared with ... options in the car camera industry. , The need ... be hard to find the one that’s right per ...
(Date:11/23/2014)... Utah (PRWEB) November 23, 2014 ... insurance reimbursement for small businesses, announced their new ... The End of Employer-Provided Health Insurance. ... is the greatest financial risk facing most American ... U.S. employers, small and large, when it comes ...
Breaking Medicine News(10 mins):Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:A Leader in Front and Rear Facing In-Car Cameras was Featured on NewsWatch Television on October 30, 2014 2Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2
... have hit a plateau, report says , , TUESDAY, April ... death rates seem to have stagnated, a new report ... that fueled recent declines in cancer deaths appear to ... terms of people smoking and getting necessary screening. The ...
... Board of Directors, SAN JOSE, Calif., April ... home improvement retailer, today announced a,partnership with Canary ... the funding, discovery and development of,tests for early ... OSH has been appointed to Canary Foundation,s Board ...
... spike in blood flow to heart, study finds , , ... a gene variation in heart disease patients who are ... that it causes a major reduction in blood flow ... with this particular variation of the adrenergic beta-1 receptor ...
... are dying even sooner than before, report shows , , ... belief, life expectancies are not rising steadily and uniformly ... shows that between 1983 and 1999, death rates for ... geographical and racial disparities in life expectancy have worsened ...
... PORTLAND, Ore. An Oregon Health & Science University ... a strong indicator of survival for men with advanced ... is a special type of protein produced by the ... "This could mean that a simple blood test that ...
... The Robert Wood Johnson Foundations Physician Faculty Scholars ... Jane Brotanek, assistant professor of pediatrics at UT Southwestern ... which investigates the relationship between infant feeding practices and ... one of a small group of junior faculty nationwide ...
Cached Medicine News:Health News:Factors in Cancer Death Rates Stay Stagnant 2Health News:Factors in Cancer Death Rates Stay Stagnant 3Health News:Orchard Supply Hardware Partners With Canary Foundation 2Health News:Orchard Supply Hardware Partners With Canary Foundation 3Health News:Gene Variant Boosts Risk for Stress-Related Ischemia 2Health News:Disparities in Life Expectancy Increasing 2Health News:Disparities in Life Expectancy Increasing 3Health News:OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival 2Health News:UT Southwestern Medical Center receives grant from the Robert Wood Johnson Foundation 2
... provide molecular labs a more advanced alternative ... our MGB technology, combined with post-PCR dissociation ... to provide molecular labs more powerful tools ... organisms or genetic mutations associated with disease, ...
... are specifically designed for PCR amplification ... fluorescence detection systems. The NGEN product ... of mutations associated with cystic fibrosis, ... as reagents for the detection of ...
... Reagents provide molecular labs a more advanced ... using our MGB technology, combined with post-PCR ... able to provide molecular labs more powerful ... specific organisms or genetic mutations associated with ...
... In pregnancy testing, our new ICON 25 ... gives you fast, accurate results, plus Beckman ... 25 hCG offers CLIA waived simplicity for ... serum. For the hospital, it's the perfect ...
Medicine Products: